Global Neuroscience Antibodies & Assays Market
Medical Equipment

Neuroscience Antibodies & Assays Market Expansion Forecast Reaching $9.83 Billion By 2030 At 14.3% CAGR

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Neuroscience Antibodies & Assays Market Progress Between 2026 And 2030?

The neuroscience antibodies & assays market has undergone rapid expansion in recent years. It is projected to grow from $5.03 billion in 2025 to $5.76 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.5%. This growth observed in the past can be ascribed to factors such as the increasing prevalence of neurological disorders, the expansion of neuroscience research funding, a greater utilization of immunoassays in diagnostics, the availability of advanced laboratory instruments, and the proliferation of academic neuroscience programs.

The neuroscience antibodies & assays market is projected to experience significant expansion over the next few years, with its size expected to reach $9.83 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 14.3%. This growth during the forecast period is attributed to several factors, including increasing investments in neurodegenerative disease research, a rising demand for personalized neurology diagnostics, the expansion of drug discovery programs, the growing adoption of automated assay platforms, and an increasing focus on early disease detection. Furthermore, major trends in the forecast period include the increasing adoption of high-specificity antibody reagents, the rising use of multiplex assay platforms, the growing integration of automation in neuro research labs, the expansion of biomarker-based neurological studies, and an enhanced focus on reproducibility and sensitivity.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/neuroscience-antibodies-and-assays-global-market-report

What Factors Are Contributing To The Growth Of The Neuroscience Antibodies & Assays Market?

Rising occurrences of neurological conditions are anticipated to fuel the expansion of the neuroscience antibodies and assays market in the future. These conditions involve disorders impacting the brain, spinal cord, and nerves, leading to diminished cognitive, motor, or sensory capabilities. The growing frequency of neurological illnesses is primarily due to an aging population, given that an increasing percentage of older individuals in developed nations contributes to a higher prevalence of age-associated neurological conditions like Alzheimer’s disease and Parkinson’s disease. The rising incidence of neurological conditions boosts the need for specialized antibodies and assays, as these diagnostic and research instruments are essential for researchers and clinicians to identify, investigate, and track disease-specific biomarkers and protein irregularities within neurological disorders. For example, data from March 2023, provided by the Alzheimer’s Association, a US-based nonprofit voluntary health organization, indicated that in 2023, about 6.7 million Americans aged 65 and older were experiencing Alzheimer’s dementia, a figure expected to increase to 13.8 million by 2060. Consequently, the heightened occurrence of neurological illnesses is propelling the expansion of the neuroscience antibodies and assays market.

How Is The Neuroscience Antibodies & Assays Market Segmented Across Different Segment Categories?

The neuroscience antibodies & assays market covered in this report is segmented –

1) By Product: Consumables, Instruments

2) By Technology: Molecular Diagnostics, Immunoassays Or Immunochemistry, Other Technologies

3) By Application: In Vitro Diagnostics, Research, Drug Discovery

4) By End User: Hospitals And Diagnostics Centers, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies

Subsegments:

1) By Consumables: Antibodies, Assay Kits

2) By Instruments: Spectrophotometers, Microplate Readers, Flow Cytometers, Western Blotting Systems, Imaging Systems, Automated Workstations

What Trends Are Shaping The Future Of The Neuroscience Antibodies & Assays Market?

Leading companies within the neuroscience antibodies and assays market are concentrating on the development of innovative products, such as bispecific in vivo–ready antibodies, designed to simultaneously target multiple neurological pathways for more precise and effective research outcomes. These bispecific in vivo–ready antibodies are engineered to bind two distinct targets concurrently and are formulated for use in live animal models, thereby assisting researchers in modulating multiple neurological pathways at once for more precise and physiologically relevant neuroscience studies. For instance, in October 2025, Bio X Cell LLC, a US–based biotechnology company, launched an expanded catalog of bispecific and ADC (antibody-drug conjugate) antibodies as part of its refreshed brand identity, specifically targeting advanced preclinical neuroscience and translational research applications. These particular bispecific antibodies are engineered to bind two separate antigens simultaneously, enabling researchers to modulate multiple signaling pathways or cell populations in the brain within a single study, unlike traditional monoclonal antibodies that target only one molecule. They are produced with high purity (= 95%) and ultra-low endotoxin levels (= 0.5 EU/mg), making them well-suited for sensitive in vivo experiments, organoid models, and organ-on-chip systems. Furthermore, the ADCs combine a functional antibody with a cytotoxic payload to selectively target specific neuronal or glial populations, offering precise modulation and experimental flexibility.

Which Organizations Play A Role In The Neuroscience Antibodies & Assays Market Landscape?

Major companies operating in the neuroscience antibodies & assays market are Abcam plc, BioLegend Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Merck KGaA, Rockland Immunochemicals Inc., GenScript Biotech Corporation, Santa Cruz Biotechnology Inc., Wak-Chemie Medical GmbH, Epitope Diagnostics Inc., Agilent Technologies, Bio-Techne Corporation, Creative Diagnostics, Enzo Life Sciences Inc., Jackson ImmunoResearch Laboratories Inc., Novus Biologicals LLC, OriGene Technologies Inc., Proteintech Group Inc., R&D Systems Inc., RayBiotech Inc., StressMarq Biosciences Inc., Synaptic Systems GmbH, Tocris Bioscience, Alomone Labs Ltd., AnaSpec Inc., Antibodies.com, Antibody Solutions, Arbor Assays, Uscn Life Science Inc., Zymo Research Corp., AAT Bioquest Inc., Abbexa Ltd., ACROBiosystems Inc., Active Motif Inc., AdipoGen Life Sciences, Advanced Targeting Systems Inc., AgriSera AB

Get The Full Neuroscience Antibodies & Assays Market Report:

https://www.thebusinessresearchcompany.com/report/neuroscience-antibodies-and-assays-global-market-report

Which Region Holds The Highest Market Share In The Neuroscience Antibodies & Assays Market?

North America was the largest region in the neuroscience antibodies & assays market in 2025. The regions covered in the neuroscience antibodies & assays market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Neuroscience Antibodies & Assays Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/neuroscience-antibodies-and-assays-global-market-report

Browse Through More Reports Similar to the Global Neuroscience Antibodies & Assays Market 2026, By The Business Research Company

Neurological Biomarkers Market Report 2026

https://www.thebusinessresearchcompany.com/report/neurological-biomarkers-global-market-report

Next Generation Antibody Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/next-generation-antibody-therapeutics-global-market-report

Antibody Discovery Market Report 2026

https://www.thebusinessresearchcompany.com/report/antibody-discovery-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model